CD8A and COVID-19: Given the ability of IL-10 to potently induce T cell activation in various cancer models (17), a final piece of evidence supporting the potential pro-inflammatory actions of IL-10 in COVID-19, is the observation of overactivated CD8+ T cells despite a reduction in overall CD8+ T cell count (24).